Bain Capital Life Sciences Investors, LLC Aeglea Bio Therapeutics, Inc. Transaction History

Bain Capital Life Sciences Investors, LLC

  • $557 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
BUY
$0.5 - $2.66 $1.25 Million - $6.65 Million
2,500,000 Added 87.79%
5,347,689 $2.7 Million
Q3 2021

Nov 15, 2021
BUY
$6.03 - $7.95 $890,564 - $1.17 Million
147,689 Added 5.47%
2,847,689 $22.6 Million
Q2 2020

Aug 14, 2020
BUY
$4.01 - $11.04 $10.8 Million - $29.8 Million
2,700,000 New
2,700,000 $25 Million

Others Institutions Holding AGLE

# of Institutions
1
Shares Held
241K
Call Options Held
0
Put Options Held
0
View Full List

About Aeglea BioTherapeutics, Inc.

AGLE Quotes by TradingView
  • Ticker AGLE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 61,172,500
  • Market Cap $1.69B
  • Description
  • Aeglea BioTherapeutics, Inc., a clinical-stage biotechnology company, designs and develops human enzyme therapeutics for the treatment of patients and families with rare metabolic diseases. The company's lead product candidate is pegzilarginase, a recombinant human Arginase 1 that is in Phase III PEACE trial to evaluate the safety and efficacy f...
More about AGLE
Track This Portfolio

Track Bain Capital Life Sciences Investors, LLC Portfolio

Follow Bain Capital Life Sciences Investors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bain Capital Life Sciences Investors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bain Capital Life Sciences Investors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email